NASDAQ:CYCN   Cyclerion Therapeutics, Inc
This stock is sitting nicely on daily chart , but what it great a hedge fund owns 71 percent of shares, back in december of 2019 hedge fund bought second round of shares and if you look at chart thats when price moved up, this is a long term call but you should be in profit sooner than later